UXN Co., Ltd.
12Patents
12Active
12Granted
45Portfolio score
Filing activity: Dec 15, 2017 → Mar 1, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10040948B1 | Method of making a colloid and nanoporous layer | Emerging Cross-Sectional Technologies | 4 | Active |
| US10687746B2 | Method of making nanoparticle colloid and nanoporous layer | Emerging Cross-Sectional Technologies | 4 | Active |
| US11278224B2 | Method of making nanoparticle colloid and nanoporous layer | Emerging Cross-Sectional Technologies | 2 | Active |
| US11717199B2 | Method of making nanoparticle colloid and nanoporous layer | Emerging Cross-Sectional Technologies | 0 | Active |
| US10107776B1 | Glucose-sensing device with maltose blocking layer | Emerging Cross-Sectional Technologies | 0 | Active |
| US11134873B2 | Glucose-sensing device with maltose blocking layer | Emerging Cross-Sectional Technologies | 0 | Active |
| US11751781B2 | Glucose-sensing electrode and device with nanoporous layer | Emerging Cross-Sectional Technologies | 0 | Active |
| US10330628B2 | Glucose-sensing electrode and device with nanoporous layer | Emerging Cross-Sectional Technologies | 0 | Active |
| US10327684B2 | Glucose sensor apparatus addressing interference of ascorbic acid and acetaminophen | Emerging Cross-Sectional Technologies | 0 | Active |
| US11166655B2 | Non-enzymatic glucose-sensing device with nanoporous structure and conditioning of the nanoporous structure | Emerging Cross-Sectional Technologies | 0 | Active |
| US11744493B2 | Glucose sensor apparatus addressing interference of ascorbic acid and acetaminophen | Emerging Cross-Sectional Technologies | 0 | Active |
| US10130290B1 | Non-enzymatic glucose-sensing device with nanoporous structure and conditioning of the nanoporous structure | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.